nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CA7—colon cancer	0.762	1	CbGaD
Indapamide—CA5A—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0172	0.185	CbGpPWpGaD
Indapamide—CA5B—Reversible hydration of carbon dioxide—CA7—colon cancer	0.016	0.172	CbGpPWpGaD
Indapamide—CA12—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0149	0.16	CbGpPWpGaD
Indapamide—CA4—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0119	0.127	CbGpPWpGaD
Indapamide—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0114	0.122	CbGpPWpGaD
Indapamide—CA9—Reversible hydration of carbon dioxide—CA7—colon cancer	0.00958	0.103	CbGpPWpGaD
Indapamide—KCNE1—renal system—colon cancer	0.00314	0.106	CbGeAlD
Indapamide—CA9—gall bladder—colon cancer	0.0029	0.0974	CbGeAlD
Indapamide—Furosemide—CA7—colon cancer	0.00207	0.281	CrCbGaD
Indapamide—Metolazone—CA7—colon cancer	0.00199	0.27	CrCbGaD
Indapamide—CA7—renal system—colon cancer	0.00158	0.0532	CbGeAlD
Indapamide—Bumetanide—CA7—colon cancer	0.00157	0.213	CrCbGaD
Indapamide—SLC12A3—renal system—colon cancer	0.00155	0.0521	CbGeAlD
Indapamide—Chlorthalidone—CA7—colon cancer	0.00154	0.208	CrCbGaD
Indapamide—CA5A—liver—colon cancer	0.00145	0.0489	CbGeAlD
Indapamide—KCNQ1—renal system—colon cancer	0.00144	0.0485	CbGeAlD
Indapamide—CA7—digestive system—colon cancer	0.0013	0.0437	CbGeAlD
Indapamide—KCNQ1—digestive system—colon cancer	0.00118	0.0398	CbGeAlD
Indapamide—CA9—digestive system—colon cancer	0.00114	0.0383	CbGeAlD
Indapamide—CA2—gall bladder—colon cancer	0.0011	0.037	CbGeAlD
Indapamide—KCNQ1—bone marrow—colon cancer	0.00109	0.0367	CbGeAlD
Indapamide—CA12—renal system—colon cancer	0.00103	0.0346	CbGeAlD
Indapamide—KCNQ1—liver—colon cancer	0.000881	0.0296	CbGeAlD
Indapamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—colon cancer	0.000879	0.00944	CbGpPWpGaD
Indapamide—CA12—digestive system—colon cancer	0.000844	0.0284	CbGeAlD
Indapamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—colon cancer	0.000832	0.00894	CbGpPWpGaD
Indapamide—CA2—embryo—colon cancer	0.000698	0.0235	CbGeAlD
Indapamide—KCNQ1—lymph node—colon cancer	0.000676	0.0227	CbGeAlD
Indapamide—CA5B—vagina—colon cancer	0.000668	0.0225	CbGeAlD
Indapamide—CA4—renal system—colon cancer	0.000637	0.0214	CbGeAlD
Indapamide—CA9—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000628	0.00675	CbGpPWpGaD
Indapamide—CA2—epithelium—colon cancer	0.000569	0.0191	CbGeAlD
Indapamide—CA2—smooth muscle tissue—colon cancer	0.000549	0.0184	CbGeAlD
Indapamide—CA2—renal system—colon cancer	0.000528	0.0178	CbGeAlD
Indapamide—CA4—digestive system—colon cancer	0.000522	0.0176	CbGeAlD
Indapamide—CA4—bone marrow—colon cancer	0.000482	0.0162	CbGeAlD
Indapamide—CA2—lymphoid tissue—colon cancer	0.000439	0.0147	CbGeAlD
Indapamide—CA2—digestive system—colon cancer	0.000433	0.0146	CbGeAlD
Indapamide—CA5B—lymph node—colon cancer	0.000432	0.0145	CbGeAlD
Indapamide—CA2—bone marrow—colon cancer	0.000399	0.0134	CbGeAlD
Indapamide—CA9—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.000392	0.00421	CbGpPWpGaD
Indapamide—CA9—Cellular response to hypoxia—EP300—colon cancer	0.000388	0.00417	CbGpPWpGaD
Indapamide—CA2—vagina—colon cancer	0.000383	0.0129	CbGeAlD
Indapamide—CA9—Cellular response to hypoxia—VEGFA—colon cancer	0.000367	0.00395	CbGpPWpGaD
Indapamide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000357	0.00384	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CA7—colon cancer	0.000349	0.00375	CbGpPWpGaD
Indapamide—CYP3A4—renal system—colon cancer	0.000341	0.0115	CbGeAlD
Indapamide—CA5B—Metabolism—CA7—colon cancer	0.000326	0.0035	CbGpPWpGaD
Indapamide—CA2—liver—colon cancer	0.000323	0.0108	CbGeAlD
Indapamide—CA12—Metabolism—CA7—colon cancer	0.000302	0.00325	CbGpPWpGaD
Indapamide—CA4—lymph node—colon cancer	0.000298	0.01	CbGeAlD
Indapamide—CYP3A4—digestive system—colon cancer	0.000279	0.00939	CbGeAlD
Indapamide—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000249	0.00268	CbGpPWpGaD
Indapamide—CA2—lymph node—colon cancer	0.000247	0.00832	CbGeAlD
Indapamide—CA4—Metabolism—CA7—colon cancer	0.000241	0.00259	CbGpPWpGaD
Indapamide—CA2—Metabolism—CA7—colon cancer	0.000231	0.00248	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000217	0.00233	CbGpPWpGaD
Indapamide—Bumetanide—PTGS2—colon cancer	0.000215	0.0292	CrCbGaD
Indapamide—CA5A—Metabolism—CHST5—colon cancer	0.000212	0.00227	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ODC1—colon cancer	0.000212	0.00227	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000209	0.00224	CbGpPWpGaD
Indapamide—CYP3A4—liver—colon cancer	0.000208	0.007	CbGeAlD
Indapamide—CA7—Metabolism—ODC1—colon cancer	0.000198	0.00212	CbGpPWpGaD
Indapamide—CA7—Metabolism—CHST5—colon cancer	0.000198	0.00212	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CHST5—colon cancer	0.000198	0.00212	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ODC1—colon cancer	0.000198	0.00212	CbGpPWpGaD
Indapamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000195	0.0021	CbGpPWpGaD
Indapamide—Lethargy—Methotrexate—colon cancer	0.000195	0.0018	CcSEcCtD
Indapamide—Cerebrovascular accident—Methotrexate—colon cancer	0.000195	0.0018	CcSEcCtD
Indapamide—CA9—Metabolism—CA7—colon cancer	0.000195	0.00209	CbGpPWpGaD
Indapamide—Renal failure—Capecitabine—colon cancer	0.000194	0.0018	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—EP300—colon cancer	0.000194	0.00209	CbGpPWpGaD
Indapamide—Discomfort—Irinotecan—colon cancer	0.000194	0.0018	CcSEcCtD
Indapamide—Oedema—Vincristine—colon cancer	0.000193	0.00179	CcSEcCtD
Indapamide—Anaphylactic shock—Vincristine—colon cancer	0.000193	0.00179	CcSEcCtD
Indapamide—Stomatitis—Capecitabine—colon cancer	0.000193	0.00178	CcSEcCtD
Indapamide—Jaundice—Capecitabine—colon cancer	0.000193	0.00178	CcSEcCtD
Indapamide—Infection—Vincristine—colon cancer	0.000192	0.00178	CcSEcCtD
Indapamide—Conjunctivitis—Capecitabine—colon cancer	0.000192	0.00178	CcSEcCtD
Indapamide—Urinary tract infection—Capecitabine—colon cancer	0.000192	0.00178	CcSEcCtD
Indapamide—Osteoarthritis—Methotrexate—colon cancer	0.000191	0.00177	CcSEcCtD
Indapamide—Nervous system disorder—Vincristine—colon cancer	0.00019	0.00176	CcSEcCtD
Indapamide—Thrombocytopenia—Vincristine—colon cancer	0.000189	0.00175	CcSEcCtD
Indapamide—Anaphylactic shock—Irinotecan—colon cancer	0.000188	0.00174	CcSEcCtD
Indapamide—Oedema—Irinotecan—colon cancer	0.000188	0.00174	CcSEcCtD
Indapamide—Myalgia—Fluorouracil—colon cancer	0.000188	0.00174	CcSEcCtD
Indapamide—Chest pain—Fluorouracil—colon cancer	0.000188	0.00174	CcSEcCtD
Indapamide—Infection—Irinotecan—colon cancer	0.000187	0.00173	CcSEcCtD
Indapamide—Hyperhidrosis—Vincristine—colon cancer	0.000187	0.00173	CcSEcCtD
Indapamide—Hepatobiliary disease—Capecitabine—colon cancer	0.000187	0.00173	CcSEcCtD
Indapamide—Discomfort—Fluorouracil—colon cancer	0.000186	0.00172	CcSEcCtD
Indapamide—Shock—Irinotecan—colon cancer	0.000185	0.00172	CcSEcCtD
Indapamide—Nervous system disorder—Irinotecan—colon cancer	0.000185	0.00171	CcSEcCtD
Indapamide—Agranulocytosis—Capecitabine—colon cancer	0.000184	0.00171	CcSEcCtD
Indapamide—Thrombocytopenia—Irinotecan—colon cancer	0.000184	0.00171	CcSEcCtD
Indapamide—Anorexia—Vincristine—colon cancer	0.000184	0.00171	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000184	0.00198	CbGpPWpGaD
Indapamide—CA12—Metabolism—ODC1—colon cancer	0.000183	0.00197	CbGpPWpGaD
Indapamide—CA12—Metabolism—CHST5—colon cancer	0.000183	0.00197	CbGpPWpGaD
Indapamide—Irritability—Methotrexate—colon cancer	0.000182	0.00169	CcSEcCtD
Indapamide—Hyperhidrosis—Irinotecan—colon cancer	0.000182	0.00169	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—BRAF—colon cancer	0.000182	0.00195	CbGpPWpGaD
Indapamide—Hypotension—Vincristine—colon cancer	0.000181	0.00167	CcSEcCtD
Indapamide—Anaphylactic shock—Fluorouracil—colon cancer	0.00018	0.00167	CcSEcCtD
Indapamide—Oedema—Fluorouracil—colon cancer	0.00018	0.00167	CcSEcCtD
Indapamide—Anorexia—Irinotecan—colon cancer	0.000179	0.00166	CcSEcCtD
Indapamide—Ataxia—Methotrexate—colon cancer	0.000179	0.00166	CcSEcCtD
Indapamide—Infection—Fluorouracil—colon cancer	0.000179	0.00166	CcSEcCtD
Indapamide—CA9—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000178	0.00192	CbGpPWpGaD
Indapamide—Rhinitis—Capecitabine—colon cancer	0.000178	0.00165	CcSEcCtD
Indapamide—Hepatitis—Capecitabine—colon cancer	0.000177	0.00164	CcSEcCtD
Indapamide—Nervous system disorder—Fluorouracil—colon cancer	0.000177	0.00164	CcSEcCtD
Indapamide—Thrombocytopenia—Fluorouracil—colon cancer	0.000177	0.00164	CcSEcCtD
Indapamide—Hypoaesthesia—Capecitabine—colon cancer	0.000176	0.00164	CcSEcCtD
Indapamide—Liver function test abnormal—Methotrexate—colon cancer	0.000176	0.00163	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Vincristine—colon cancer	0.000176	0.00163	CcSEcCtD
Indapamide—Pharyngitis—Capecitabine—colon cancer	0.000176	0.00163	CcSEcCtD
Indapamide—Tachycardia—Fluorouracil—colon cancer	0.000176	0.00163	CcSEcCtD
Indapamide—Hypotension—Irinotecan—colon cancer	0.000176	0.00163	CcSEcCtD
Indapamide—Urinary tract disorder—Capecitabine—colon cancer	0.000175	0.00162	CcSEcCtD
Indapamide—Insomnia—Vincristine—colon cancer	0.000175	0.00162	CcSEcCtD
Indapamide—Oedema peripheral—Capecitabine—colon cancer	0.000175	0.00162	CcSEcCtD
Indapamide—Urethral disorder—Capecitabine—colon cancer	0.000174	0.00161	CcSEcCtD
Indapamide—Paraesthesia—Vincristine—colon cancer	0.000174	0.00161	CcSEcCtD
Indapamide—Anorexia—Fluorouracil—colon cancer	0.000172	0.00159	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000172	0.00159	CcSEcCtD
Indapamide—Visual impairment—Capecitabine—colon cancer	0.000171	0.00158	CcSEcCtD
Indapamide—Insomnia—Irinotecan—colon cancer	0.00017	0.00158	CcSEcCtD
Indapamide—Paraesthesia—Irinotecan—colon cancer	0.000169	0.00157	CcSEcCtD
Indapamide—CA9—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000169	0.00182	CbGpPWpGaD
Indapamide—Hypotension—Fluorouracil—colon cancer	0.000169	0.00156	CcSEcCtD
Indapamide—Decreased appetite—Vincristine—colon cancer	0.000168	0.00156	CcSEcCtD
Indapamide—Dyspnoea—Irinotecan—colon cancer	0.000168	0.00156	CcSEcCtD
Indapamide—Erythema multiforme—Capecitabine—colon cancer	0.000168	0.00155	CcSEcCtD
Indapamide—Somnolence—Irinotecan—colon cancer	0.000167	0.00155	CcSEcCtD
Indapamide—Gastrointestinal disorder—Vincristine—colon cancer	0.000167	0.00155	CcSEcCtD
Indapamide—Fatigue—Vincristine—colon cancer	0.000167	0.00154	CcSEcCtD
Indapamide—Dyspepsia—Irinotecan—colon cancer	0.000166	0.00154	CcSEcCtD
Indapamide—Tinnitus—Capecitabine—colon cancer	0.000165	0.00153	CcSEcCtD
Indapamide—Pain—Vincristine—colon cancer	0.000165	0.00153	CcSEcCtD
Indapamide—Constipation—Vincristine—colon cancer	0.000165	0.00153	CcSEcCtD
Indapamide—Asthma—Methotrexate—colon cancer	0.000165	0.00153	CcSEcCtD
Indapamide—Flushing—Capecitabine—colon cancer	0.000165	0.00153	CcSEcCtD
Indapamide—Cardiac disorder—Capecitabine—colon cancer	0.000165	0.00153	CcSEcCtD
Indapamide—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000164	0.00177	CbGpPWpGaD
Indapamide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000164	0.00152	CcSEcCtD
Indapamide—Decreased appetite—Irinotecan—colon cancer	0.000164	0.00152	CcSEcCtD
Indapamide—Insomnia—Fluorouracil—colon cancer	0.000163	0.00151	CcSEcCtD
Indapamide—Gastrointestinal disorder—Irinotecan—colon cancer	0.000163	0.00151	CcSEcCtD
Indapamide—Fatigue—Irinotecan—colon cancer	0.000162	0.0015	CcSEcCtD
Indapamide—Paraesthesia—Fluorouracil—colon cancer	0.000162	0.0015	CcSEcCtD
Indapamide—Pancreatitis—Methotrexate—colon cancer	0.000162	0.0015	CcSEcCtD
Indapamide—Constipation—Irinotecan—colon cancer	0.000161	0.00149	CcSEcCtD
Indapamide—Pain—Irinotecan—colon cancer	0.000161	0.00149	CcSEcCtD
Indapamide—Dyspnoea—Fluorouracil—colon cancer	0.000161	0.00149	CcSEcCtD
Indapamide—Somnolence—Fluorouracil—colon cancer	0.00016	0.00149	CcSEcCtD
Indapamide—Dyspepsia—Fluorouracil—colon cancer	0.000159	0.00147	CcSEcCtD
Indapamide—Arrhythmia—Capecitabine—colon cancer	0.000158	0.00147	CcSEcCtD
Indapamide—Gastrointestinal pain—Vincristine—colon cancer	0.000158	0.00147	CcSEcCtD
Indapamide—Decreased appetite—Fluorouracil—colon cancer	0.000157	0.00145	CcSEcCtD
Indapamide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000156	0.00144	CcSEcCtD
Indapamide—Feeling abnormal—Irinotecan—colon cancer	0.000155	0.00144	CcSEcCtD
Indapamide—Erythema—Capecitabine—colon cancer	0.000154	0.00143	CcSEcCtD
Indapamide—Malnutrition—Capecitabine—colon cancer	0.000154	0.00143	CcSEcCtD
Indapamide—Dysuria—Methotrexate—colon cancer	0.000154	0.00143	CcSEcCtD
Indapamide—Pain—Fluorouracil—colon cancer	0.000154	0.00143	CcSEcCtD
Indapamide—Gastrointestinal pain—Irinotecan—colon cancer	0.000154	0.00143	CcSEcCtD
Indapamide—Body temperature increased—Vincristine—colon cancer	0.000153	0.00142	CcSEcCtD
Indapamide—Abdominal pain—Vincristine—colon cancer	0.000153	0.00142	CcSEcCtD
Indapamide—Flatulence—Capecitabine—colon cancer	0.000152	0.00141	CcSEcCtD
Indapamide—Erectile dysfunction—Methotrexate—colon cancer	0.000152	0.00141	CcSEcCtD
Indapamide—Dysgeusia—Capecitabine—colon cancer	0.000151	0.0014	CcSEcCtD
Indapamide—Photosensitivity reaction—Methotrexate—colon cancer	0.000151	0.0014	CcSEcCtD
Indapamide—Back pain—Capecitabine—colon cancer	0.000149	0.00138	CcSEcCtD
Indapamide—Abdominal pain—Irinotecan—colon cancer	0.000149	0.00138	CcSEcCtD
Indapamide—Body temperature increased—Irinotecan—colon cancer	0.000149	0.00138	CcSEcCtD
Indapamide—Feeling abnormal—Fluorouracil—colon cancer	0.000149	0.00138	CcSEcCtD
Indapamide—Muscle spasms—Capecitabine—colon cancer	0.000148	0.00138	CcSEcCtD
Indapamide—Pneumonia—Methotrexate—colon cancer	0.000148	0.00137	CcSEcCtD
Indapamide—Drowsiness—Methotrexate—colon cancer	0.000147	0.00136	CcSEcCtD
Indapamide—Depression—Methotrexate—colon cancer	0.000147	0.00136	CcSEcCtD
Indapamide—CA4—Metabolism—CHST5—colon cancer	0.000146	0.00157	CbGpPWpGaD
Indapamide—CA4—Metabolism—ODC1—colon cancer	0.000146	0.00157	CbGpPWpGaD
Indapamide—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000146	0.00135	CcSEcCtD
Indapamide—Vision blurred—Capecitabine—colon cancer	0.000146	0.00135	CcSEcCtD
Indapamide—Renal failure—Methotrexate—colon cancer	0.000145	0.00134	CcSEcCtD
Indapamide—Stomatitis—Methotrexate—colon cancer	0.000143	0.00133	CcSEcCtD
Indapamide—Ill-defined disorder—Capecitabine—colon cancer	0.000143	0.00133	CcSEcCtD
Indapamide—Urticaria—Fluorouracil—colon cancer	0.000143	0.00133	CcSEcCtD
Indapamide—Conjunctivitis—Methotrexate—colon cancer	0.000143	0.00132	CcSEcCtD
Indapamide—Anaemia—Capecitabine—colon cancer	0.000143	0.00132	CcSEcCtD
Indapamide—Body temperature increased—Fluorouracil—colon cancer	0.000143	0.00132	CcSEcCtD
Indapamide—Hypersensitivity—Vincristine—colon cancer	0.000142	0.00132	CcSEcCtD
Indapamide—Sweating—Methotrexate—colon cancer	0.000141	0.00131	CcSEcCtD
Indapamide—CA2—Metabolism—ODC1—colon cancer	0.00014	0.0015	CbGpPWpGaD
Indapamide—CA2—Metabolism—CHST5—colon cancer	0.00014	0.0015	CbGpPWpGaD
Indapamide—Malaise—Capecitabine—colon cancer	0.000139	0.00129	CcSEcCtD
Indapamide—Hepatobiliary disease—Methotrexate—colon cancer	0.000139	0.00129	CcSEcCtD
Indapamide—Vertigo—Capecitabine—colon cancer	0.000139	0.00129	CcSEcCtD
Indapamide—Hypersensitivity—Irinotecan—colon cancer	0.000139	0.00129	CcSEcCtD
Indapamide—Asthenia—Vincristine—colon cancer	0.000139	0.00129	CcSEcCtD
Indapamide—Syncope—Capecitabine—colon cancer	0.000138	0.00128	CcSEcCtD
Indapamide—Leukopenia—Capecitabine—colon cancer	0.000138	0.00128	CcSEcCtD
Indapamide—Agranulocytosis—Methotrexate—colon cancer	0.000137	0.00127	CcSEcCtD
Indapamide—Palpitations—Capecitabine—colon cancer	0.000136	0.00126	CcSEcCtD
Indapamide—Loss of consciousness—Capecitabine—colon cancer	0.000136	0.00126	CcSEcCtD
Indapamide—Asthenia—Irinotecan—colon cancer	0.000135	0.00125	CcSEcCtD
Indapamide—Cough—Capecitabine—colon cancer	0.000135	0.00125	CcSEcCtD
Indapamide—Hypersensitivity—Fluorouracil—colon cancer	0.000133	0.00123	CcSEcCtD
Indapamide—Diarrhoea—Vincristine—colon cancer	0.000132	0.00123	CcSEcCtD
Indapamide—Hepatitis—Methotrexate—colon cancer	0.000132	0.00122	CcSEcCtD
Indapamide—Arthralgia—Capecitabine—colon cancer	0.000131	0.00122	CcSEcCtD
Indapamide—Chest pain—Capecitabine—colon cancer	0.000131	0.00122	CcSEcCtD
Indapamide—Myalgia—Capecitabine—colon cancer	0.000131	0.00122	CcSEcCtD
Indapamide—Pharyngitis—Methotrexate—colon cancer	0.000131	0.00121	CcSEcCtD
Indapamide—Anxiety—Capecitabine—colon cancer	0.000131	0.00121	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000131	0.00121	CcSEcCtD
Indapamide—Urinary tract disorder—Methotrexate—colon cancer	0.00013	0.00121	CcSEcCtD
Indapamide—Discomfort—Capecitabine—colon cancer	0.00013	0.0012	CcSEcCtD
Indapamide—Urethral disorder—Methotrexate—colon cancer	0.000129	0.0012	CcSEcCtD
Indapamide—Diarrhoea—Irinotecan—colon cancer	0.000129	0.00119	CcSEcCtD
Indapamide—Dry mouth—Capecitabine—colon cancer	0.000129	0.00119	CcSEcCtD
Indapamide—Dizziness—Vincristine—colon cancer	0.000128	0.00118	CcSEcCtD
Indapamide—Pruritus—Fluorouracil—colon cancer	0.000128	0.00118	CcSEcCtD
Indapamide—Visual impairment—Methotrexate—colon cancer	0.000127	0.00118	CcSEcCtD
Indapamide—Oedema—Capecitabine—colon cancer	0.000126	0.00117	CcSEcCtD
Indapamide—Infection—Capecitabine—colon cancer	0.000125	0.00116	CcSEcCtD
Indapamide—Erythema multiforme—Methotrexate—colon cancer	0.000125	0.00116	CcSEcCtD
Indapamide—Dizziness—Irinotecan—colon cancer	0.000125	0.00115	CcSEcCtD
Indapamide—Shock—Capecitabine—colon cancer	0.000124	0.00115	CcSEcCtD
Indapamide—Nervous system disorder—Capecitabine—colon cancer	0.000124	0.00115	CcSEcCtD
Indapamide—Diarrhoea—Fluorouracil—colon cancer	0.000123	0.00114	CcSEcCtD
Indapamide—Thrombocytopenia—Capecitabine—colon cancer	0.000123	0.00114	CcSEcCtD
Indapamide—Tinnitus—Methotrexate—colon cancer	0.000123	0.00114	CcSEcCtD
Indapamide—Tachycardia—Capecitabine—colon cancer	0.000123	0.00114	CcSEcCtD
Indapamide—Vomiting—Vincristine—colon cancer	0.000123	0.00114	CcSEcCtD
Indapamide—Cardiac disorder—Methotrexate—colon cancer	0.000123	0.00114	CcSEcCtD
Indapamide—Skin disorder—Capecitabine—colon cancer	0.000122	0.00113	CcSEcCtD
Indapamide—Rash—Vincristine—colon cancer	0.000122	0.00113	CcSEcCtD
Indapamide—Hyperhidrosis—Capecitabine—colon cancer	0.000122	0.00113	CcSEcCtD
Indapamide—Dermatitis—Vincristine—colon cancer	0.000122	0.00113	CcSEcCtD
Indapamide—Headache—Vincristine—colon cancer	0.000121	0.00112	CcSEcCtD
Indapamide—Anorexia—Capecitabine—colon cancer	0.00012	0.00111	CcSEcCtD
Indapamide—Vomiting—Irinotecan—colon cancer	0.00012	0.00111	CcSEcCtD
Indapamide—Dizziness—Fluorouracil—colon cancer	0.000119	0.00111	CcSEcCtD
Indapamide—Rash—Irinotecan—colon cancer	0.000119	0.0011	CcSEcCtD
Indapamide—Dermatitis—Irinotecan—colon cancer	0.000119	0.0011	CcSEcCtD
Indapamide—Headache—Irinotecan—colon cancer	0.000118	0.00109	CcSEcCtD
Indapamide—CA9—Metabolism—ODC1—colon cancer	0.000118	0.00127	CbGpPWpGaD
Indapamide—CA9—Metabolism—CHST5—colon cancer	0.000118	0.00127	CbGpPWpGaD
Indapamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000118	0.00127	CbGpPWpGaD
Indapamide—Hypotension—Capecitabine—colon cancer	0.000118	0.00109	CcSEcCtD
Indapamide—Erythema—Methotrexate—colon cancer	0.000115	0.00107	CcSEcCtD
Indapamide—Malnutrition—Methotrexate—colon cancer	0.000115	0.00107	CcSEcCtD
Indapamide—Nausea—Vincristine—colon cancer	0.000115	0.00106	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000115	0.00106	CcSEcCtD
Indapamide—Vomiting—Fluorouracil—colon cancer	0.000115	0.00106	CcSEcCtD
Indapamide—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000114	0.00123	CbGpPWpGaD
Indapamide—Insomnia—Capecitabine—colon cancer	0.000114	0.00106	CcSEcCtD
Indapamide—Rash—Fluorouracil—colon cancer	0.000114	0.00105	CcSEcCtD
Indapamide—Dermatitis—Fluorouracil—colon cancer	0.000114	0.00105	CcSEcCtD
Indapamide—Paraesthesia—Capecitabine—colon cancer	0.000113	0.00105	CcSEcCtD
Indapamide—Headache—Fluorouracil—colon cancer	0.000113	0.00105	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—colon cancer	0.000113	0.00104	CcSEcCtD
Indapamide—Dyspnoea—Capecitabine—colon cancer	0.000112	0.00104	CcSEcCtD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000112	0.00121	CbGpPWpGaD
Indapamide—Nausea—Irinotecan—colon cancer	0.000112	0.00104	CcSEcCtD
Indapamide—Back pain—Methotrexate—colon cancer	0.000111	0.00103	CcSEcCtD
Indapamide—Dyspepsia—Capecitabine—colon cancer	0.000111	0.00103	CcSEcCtD
Indapamide—Decreased appetite—Capecitabine—colon cancer	0.00011	0.00102	CcSEcCtD
Indapamide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000109	0.00101	CcSEcCtD
Indapamide—Fatigue—Capecitabine—colon cancer	0.000109	0.00101	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—colon cancer	0.000108	0.001	CcSEcCtD
Indapamide—CA9—HIF-1-alpha transcription factor network—AKT1—colon cancer	0.000108	0.00116	CbGpPWpGaD
Indapamide—Pain—Capecitabine—colon cancer	0.000108	0.000999	CcSEcCtD
Indapamide—Constipation—Capecitabine—colon cancer	0.000108	0.000999	CcSEcCtD
Indapamide—Nausea—Fluorouracil—colon cancer	0.000107	0.000993	CcSEcCtD
Indapamide—Ill-defined disorder—Methotrexate—colon cancer	0.000107	0.000988	CcSEcCtD
Indapamide—Anaemia—Methotrexate—colon cancer	0.000106	0.000985	CcSEcCtD
Indapamide—Feeling abnormal—Capecitabine—colon cancer	0.000104	0.000962	CcSEcCtD
Indapamide—Malaise—Methotrexate—colon cancer	0.000104	0.000961	CcSEcCtD
Indapamide—Vertigo—Methotrexate—colon cancer	0.000103	0.000957	CcSEcCtD
Indapamide—Gastrointestinal pain—Capecitabine—colon cancer	0.000103	0.000955	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—colon cancer	0.000103	0.000953	CcSEcCtD
Indapamide—Cough—Methotrexate—colon cancer	0.0001	0.00093	CcSEcCtD
Indapamide—Urticaria—Capecitabine—colon cancer	0.0001	0.000928	CcSEcCtD
Indapamide—Abdominal pain—Capecitabine—colon cancer	9.96e-05	0.000923	CcSEcCtD
Indapamide—Body temperature increased—Capecitabine—colon cancer	9.96e-05	0.000923	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—colon cancer	9.79e-05	0.000907	CcSEcCtD
Indapamide—Chest pain—Methotrexate—colon cancer	9.79e-05	0.000907	CcSEcCtD
Indapamide—Myalgia—Methotrexate—colon cancer	9.79e-05	0.000907	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	9.72e-05	0.000901	CcSEcCtD
Indapamide—Discomfort—Methotrexate—colon cancer	9.67e-05	0.000896	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ABCB1—colon cancer	9.54e-05	0.00103	CbGpPWpGaD
Indapamide—Anaphylactic shock—Methotrexate—colon cancer	9.38e-05	0.000869	CcSEcCtD
Indapamide—Infection—Methotrexate—colon cancer	9.32e-05	0.000864	CcSEcCtD
Indapamide—Hypersensitivity—Capecitabine—colon cancer	9.28e-05	0.00086	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—colon cancer	9.2e-05	0.000853	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—colon cancer	9.19e-05	0.000851	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—colon cancer	9.11e-05	0.000844	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—colon cancer	9.07e-05	0.00084	CcSEcCtD
Indapamide—Asthenia—Capecitabine—colon cancer	9.04e-05	0.000838	CcSEcCtD
Indapamide—Anorexia—Methotrexate—colon cancer	8.94e-05	0.000829	CcSEcCtD
Indapamide—Pruritus—Capecitabine—colon cancer	8.92e-05	0.000826	CcSEcCtD
Indapamide—Hypotension—Methotrexate—colon cancer	8.77e-05	0.000812	CcSEcCtD
Indapamide—Diarrhoea—Capecitabine—colon cancer	8.62e-05	0.000799	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—colon cancer	8.55e-05	0.000792	CcSEcCtD
Indapamide—Insomnia—Methotrexate—colon cancer	8.49e-05	0.000786	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—colon cancer	8.42e-05	0.000781	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—colon cancer	8.36e-05	0.000775	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—HRAS—colon cancer	8.35e-05	0.000897	CbGpPWpGaD
Indapamide—Somnolence—Methotrexate—colon cancer	8.34e-05	0.000773	CcSEcCtD
Indapamide—Dizziness—Capecitabine—colon cancer	8.33e-05	0.000772	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—colon cancer	8.26e-05	0.000765	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—colon cancer	8.16e-05	0.000756	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—colon cancer	8.1e-05	0.000751	CcSEcCtD
Indapamide—Fatigue—Methotrexate—colon cancer	8.09e-05	0.00075	CcSEcCtD
Indapamide—Pain—Methotrexate—colon cancer	8.02e-05	0.000743	CcSEcCtD
Indapamide—Vomiting—Capecitabine—colon cancer	8.01e-05	0.000743	CcSEcCtD
Indapamide—Rash—Capecitabine—colon cancer	7.95e-05	0.000736	CcSEcCtD
Indapamide—Dermatitis—Capecitabine—colon cancer	7.94e-05	0.000736	CcSEcCtD
Indapamide—Headache—Capecitabine—colon cancer	7.89e-05	0.000732	CcSEcCtD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	7.81e-05	0.000839	CbGpPWpGaD
Indapamide—Feeling abnormal—Methotrexate—colon cancer	7.73e-05	0.000716	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—colon cancer	7.67e-05	0.000711	CcSEcCtD
Indapamide—Nausea—Capecitabine—colon cancer	7.49e-05	0.000694	CcSEcCtD
Indapamide—Urticaria—Methotrexate—colon cancer	7.45e-05	0.000691	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—colon cancer	7.42e-05	0.000687	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—colon cancer	7.42e-05	0.000687	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—colon cancer	6.91e-05	0.00064	CcSEcCtD
Indapamide—Asthenia—Methotrexate—colon cancer	6.73e-05	0.000624	CcSEcCtD
Indapamide—Pruritus—Methotrexate—colon cancer	6.64e-05	0.000615	CcSEcCtD
Indapamide—Diarrhoea—Methotrexate—colon cancer	6.42e-05	0.000595	CcSEcCtD
Indapamide—Dizziness—Methotrexate—colon cancer	6.2e-05	0.000575	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—CDKN1A—colon cancer	6.19e-05	0.000665	CbGpPWpGaD
Indapamide—Vomiting—Methotrexate—colon cancer	5.96e-05	0.000553	CcSEcCtD
Indapamide—Rash—Methotrexate—colon cancer	5.92e-05	0.000548	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—colon cancer	5.91e-05	0.000548	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—EP300—colon cancer	5.89e-05	0.000633	CbGpPWpGaD
Indapamide—Headache—Methotrexate—colon cancer	5.88e-05	0.000545	CcSEcCtD
Indapamide—CA5A—Metabolism—ABCB1—colon cancer	5.59e-05	0.000601	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—colon cancer	5.58e-05	0.000599	CbGpPWpGaD
Indapamide—Nausea—Methotrexate—colon cancer	5.57e-05	0.000516	CcSEcCtD
Indapamide—CA5A—Metabolism—TYMS—colon cancer	5.49e-05	0.00059	CbGpPWpGaD
Indapamide—CA7—Metabolism—ABCB1—colon cancer	5.22e-05	0.000561	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ABCB1—colon cancer	5.22e-05	0.000561	CbGpPWpGaD
Indapamide—CA5B—Metabolism—TYMS—colon cancer	5.13e-05	0.000551	CbGpPWpGaD
Indapamide—CA7—Metabolism—TYMS—colon cancer	5.13e-05	0.000551	CbGpPWpGaD
Indapamide—CA12—Metabolism—ABCB1—colon cancer	4.84e-05	0.00052	CbGpPWpGaD
Indapamide—CA12—Metabolism—TYMS—colon cancer	4.75e-05	0.00051	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—colon cancer	4.21e-05	0.000453	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PPARG—colon cancer	3.89e-05	0.000418	CbGpPWpGaD
Indapamide—CA4—Metabolism—ABCB1—colon cancer	3.86e-05	0.000414	CbGpPWpGaD
Indapamide—CA4—Metabolism—TYMS—colon cancer	3.79e-05	0.000407	CbGpPWpGaD
Indapamide—CA2—Metabolism—ABCB1—colon cancer	3.7e-05	0.000397	CbGpPWpGaD
Indapamide—CA7—Metabolism—PPARG—colon cancer	3.63e-05	0.00039	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PPARG—colon cancer	3.63e-05	0.00039	CbGpPWpGaD
Indapamide—CA2—Metabolism—TYMS—colon cancer	3.63e-05	0.00039	CbGpPWpGaD
Indapamide—CA12—Metabolism—PPARG—colon cancer	3.36e-05	0.000361	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA7—colon cancer	3.28e-05	0.000352	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCB1—colon cancer	3.12e-05	0.000335	CbGpPWpGaD
Indapamide—CA9—Metabolism—TYMS—colon cancer	3.06e-05	0.000329	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—colon cancer	3.06e-05	0.000329	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—colon cancer	2.86e-05	0.000307	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—colon cancer	2.86e-05	0.000307	CbGpPWpGaD
Indapamide—CA4—Metabolism—PPARG—colon cancer	2.68e-05	0.000288	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—colon cancer	2.65e-05	0.000284	CbGpPWpGaD
Indapamide—CA2—Metabolism—PPARG—colon cancer	2.57e-05	0.000276	CbGpPWpGaD
Indapamide—CA5A—Metabolism—EP300—colon cancer	2.54e-05	0.000273	CbGpPWpGaD
Indapamide—CA5B—Metabolism—EP300—colon cancer	2.38e-05	0.000255	CbGpPWpGaD
Indapamide—CA7—Metabolism—EP300—colon cancer	2.38e-05	0.000255	CbGpPWpGaD
Indapamide—CA12—Metabolism—EP300—colon cancer	2.2e-05	0.000236	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPARG—colon cancer	2.17e-05	0.000233	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—colon cancer	2.11e-05	0.000227	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—colon cancer	2.02e-05	0.000217	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CHST5—colon cancer	1.99e-05	0.000213	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ODC1—colon cancer	1.99e-05	0.000213	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CA—colon cancer	1.88e-05	0.000202	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CA—colon cancer	1.76e-05	0.000189	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CA—colon cancer	1.76e-05	0.000189	CbGpPWpGaD
Indapamide—CA4—Metabolism—EP300—colon cancer	1.76e-05	0.000189	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—colon cancer	1.71e-05	0.000183	CbGpPWpGaD
Indapamide—CA2—Metabolism—EP300—colon cancer	1.68e-05	0.000181	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CA—colon cancer	1.63e-05	0.000175	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKT1—colon cancer	1.54e-05	0.000165	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKT1—colon cancer	1.44e-05	0.000154	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKT1—colon cancer	1.44e-05	0.000154	CbGpPWpGaD
Indapamide—CA9—Metabolism—EP300—colon cancer	1.42e-05	0.000152	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKT1—colon cancer	1.33e-05	0.000143	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CA—colon cancer	1.3e-05	0.00014	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CA—colon cancer	1.24e-05	0.000134	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKT1—colon cancer	1.06e-05	0.000114	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CA—colon cancer	1.05e-05	0.000113	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKT1—colon cancer	1.02e-05	0.000109	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKT1—colon cancer	8.57e-06	9.21e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCB1—colon cancer	5.25e-06	5.64e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TYMS—colon cancer	5.15e-06	5.54e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARG—colon cancer	3.65e-06	3.92e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—colon cancer	2.87e-06	3.08e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—EP300—colon cancer	2.39e-06	2.57e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CA—colon cancer	1.77e-06	1.9e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKT1—colon cancer	1.44e-06	1.55e-05	CbGpPWpGaD
